Johns Hopkins Technology Ventures

Johns Hopkins Technology Ventures JHTV helps develop new discoveries and inventions into products and services that benefit society and transform the world.

JHTV is the University’s intellectual property administration center, serving Johns Hopkins researchers and inventors as a licensing, patent, and technology commercialization office. Johns Hopkins Technology Ventures (JHTV) is The Johns Hopkins University’s intellectual property administration center, serving Johns Hopkins researchers and inventors as a licensing, patent and technology commerciali

zation office and acting as an active liaison to parties interested in leveraging university research or materials for academic or corporate endeavors. In 2014, JHTV secured more than $16 million in licensing revenue, more than 2,000 active issued patents and 13 newly created startup companies. For more information about Johns Hopkins Technology Ventures, opportunities to collaborate, start a technology venture or license a technology, visit http://ventures.jhu.edu/.

Attention female innovators and business moguls at JHU! Applications for Equalize Startups are due this Friday, November...
11/12/2024

Attention female innovators and business moguls at JHU! Applications for Equalize Startups are due this Friday, November 15! Join a comprehensive entrepreneurship program for academic women inventors who want to commercialize their innovations.

Eligibility Requirements:
An academic appointment (tenured, tenure track, or research) or a post-doc or graduate student at an academic research institution.
Must have a pending or issued patent or copyright.

Elevate your entrepreneurial journey and unlock a world of opportunities designed just for you! Apply now: https://tinyurl.com/y9ptad3x

We’re excited to announce the release of JHTV’s annual report for Fiscal Year 2024! This year, we celebrate ten years of...
08/27/2024

We’re excited to announce the release of JHTV’s annual report for Fiscal Year 2024! This year, we celebrate ten years of unwavering dedication to our talented faculty and students. We invite you to take a moment to celebrate our progress, achievements, and the inventors driving innovation within the Johns Hopkins entrepreneurial community.

We deeply appreciate the many stakeholders who make this possible as we look to build on our successes in FY25 and onward!
https://ventures.jhu.edu/news/explore-jhtvs-fy24-annual-report/

Johns Hopkins University, Techstars, and CareFirst BlueCross BlueShield are teaming up to launch the Techstars AI Health...
08/23/2024

Johns Hopkins University, Techstars, and CareFirst BlueCross BlueShield are teaming up to launch the Techstars AI Health Baltimore accelerator program. This initiative will empower early-stage entrepreneurs to revolutionize healthcare through AI. With the combined expertise in this collaboration, the program aims to bring more entrepreneurs and startup activity to the Baltimore ecosystem and drive high-impact healthcare innovation to market.

The 13-week program will take place in-person in Baltimore and will focus on supporting entrepreneurs leading healthtech, medtech, and biotech startups. Applications open August 26.

https://ventures.jhu.edu/news/techstars-johns-hopkins-university-and-carefirst-bluecross-blueshield-to-bring-healthcare-a-i-accelerator-to-baltimore/

Great to see one of Johns Hopkins Technology Ventures & Johns Hopkins Applied Physics Lab startups Oculi listed as one o...
08/09/2024

Great to see one of Johns Hopkins Technology Ventures & Johns Hopkins Applied Physics Lab startups Oculi listed as one of EE|Times's 100 startups to watch!
https://bit.ly/4dgs23M

A groundbreaking new therapy was approved by the FDA on August 6th, leveraging cancer research conducted at the Johns Ho...
08/07/2024

A groundbreaking new therapy was approved by the FDA on August 6th, leveraging cancer research conducted at the Johns Hopkins Kimmel Cancer Center. Vorasidenib is a treatment for a particularly lethal type of brain cancer, called low-grade glioma. There has been little hope for those undergoing treatment for glioma – until now. https://bit.ly/3yvtCQ2

Our July Newsletter is out! Check out our new video interview and Q&A with faculty investigators, along with exciting up...
07/31/2024

Our July Newsletter is out! Check out our new video interview and Q&A with faculty investigators, along with exciting updates from our startup community and broader ecosystem! https://bit.ly/3SukfqC Kubanda Cryotherapy Leonardo DRS Rapafusyn Pharmaceuticals

New gene-editing approach offers hope to sickle cell patients! Xizhen Lian, assistant research scientist affiliated with...
07/29/2024

New gene-editing approach offers hope to sickle cell patients! Xizhen Lian, assistant research scientist affiliated with Johns Hopkins Whiting School of Engineering, the NanoBioTechnology Institute & Johns Hopkins Medicine, says "This gene editing approach would allow patients to receive the medicine through a transfusion." https://bit.ly/4c6OJ9b

Unique among universities, Johns Hopkins' research development team stands out by assisting faculty in securing large-sc...
07/26/2024

Unique among universities, Johns Hopkins' research development team stands out by assisting faculty in securing large-scale grants through their personal and tailored proposal development support and thoughtful fostering of collaboration across disciplines. https://bit.ly/4bXQRQt

07/26/2024

New Johns Hopkins Technology Ventures office hours this acadmic year, just down the hall from the CS Department—check them out!

A remarkable advance has been made at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center, the Lustgarten Labor...
07/24/2024

A remarkable advance has been made at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center, the Lustgarten Laboratory and Bloomberg~Kimmel Institute for Cancer Immunotherapy: Using genetic engineering techniques, a team of investigators, including those from JH Tech Ventures, have designed a novel type of cell to recognize and fight cancer. https://bit.ly/4fk6ODm

Address

1812 Ashland Avenue , Suite 110
Baltimore, MD
21205

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Telephone

+14106140300

Website

Alerts

Be the first to know and let us send you an email when Johns Hopkins Technology Ventures posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The University

Send a message to Johns Hopkins Technology Ventures:

Shortcuts

Share

Category